CACHD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.218600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.075500E-02
Normal-vs-Stage2
2.260000E-01
Normal-vs-Stage3
1.996990E-01
Normal-vs-Stage4
1.074030E-01
Stage1-vs-Stage2
8.587400E-01
Stage1-vs-Stage3
7.897600E-01
Stage1-vs-Stage4
8.648600E-01
Stage2-vs-Stage3
6.633600E-01
Stage2-vs-Stage4
9.631200E-01
Stage3-vs-Stage4
4.802800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.179200E-01
Normal-vs-AfricanAmerican
4.384800E-01
Normal-vs-Asian
1.761740E-02
Caucasian-vs-AfricanAmerican
2.936600E-01
Caucasian-vs-Asian
5.069400E-01
AfricanAmerican-vs-Asian
1.423980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.172200E-01
Normal-vs-Female
2.297000E-01
Male-vs-Female
5.484400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.012400E-01
Normal-vs-Age(41-60Yrs)
2.609400E-01
Normal-vs-Age(61-80Yrs)
2.122600E-01
Normal-vs-Age(81-100Yrs)
1.686640E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.729200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.712600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.295800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.299700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.817800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.651010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.022400E-01
Normal-vs-Daily Drinker
1.129950E-02
Normal-vs-Weekly Drinker
2.375800E-02
Normal-vs-Occasional Drinker
2.414600E-01
Normal-vs-Social Drinker
4.650200E-02
Non Drinker-vs-Daily Drinker
9.031800E-01
Non Drinker-vs-Weekly Drinker
7.163400E-01
Non Drinker-vs-Occasional Drinker
1.784560E-01
Non Drinker-vs-Social Drinker
2.728400E-01
Daily Drinker-vs-Weekly Drinker
8.260200E-01
Daily Drinker-vs-Occasional Drinker
4.114200E-01
Daily Drinker-vs-Social Drinker
3.897200E-01
Weekly Drinker-vs-Occasional Drinker
6.675400E-01
Weekly Drinker-vs-Social Drinker
5.587200E-01
Occasional Drinker-vs-Social Drinker
7.336600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.734440E-01
Normal-vs-Grade 2
1.097160E-01
Normal-vs-Grade 3
5.550200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.858000E-02
Grade 1-vs-Grade 3
4.034300E-02
Grade 1-vs-Grade 4
1.734440E-01
Grade 2-vs-Grade 3
6.454400E-01
Grade 2-vs-Grade 4
1.097160E-01
Grade 3-vs-Grade 4
5.550200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.206800E-01
Normal-vs-NonDiabetic
2.196000E-01
Diabetic-vs-NonDiabetic
9.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.020840E-01
Normal-vs-NoPancreatitis
2.169200E-01
Pancreatitis-vs-NoPancreatitis
5.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.089400E-01
Normal-vs-N1
2.291800E-01
N0-vs-N1
3.250200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.996810E-01
Normal-vs-TP53-NonMutant
2.529000E-01
TP53-Mutant-vs-TP53-NonMutant
8.975700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
